2023/0491 - IBRUTINIB [140 MG CÁP/COMP]
TED · 704490-2026Award noticeawardedNo deadline given
Value
Estimated€234,620 · 234,620.4 EUR
Awarded—
WinnerJANSSEN-CILAG FARMACEUTICA LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 31 | — | 2026-10-13 |
| GILEAD SCIENCES, LDA | 29 | — | 2026-10-13 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 22 | €1,569,649 | 2026-09-22 |
| JANSSEN-CILAG FARMACEUTICA LDA | 18 | €371,730 | 2026-10-13 |
| NOVARTIS FARMA - PROD.FARM SA | 17 | — | 2026-10-13 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
IBRUTINIB [140 MG CÁP/COMP]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-10-13 | 2023/0491 - IBRUTINIB [140 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-07-28 | 2023/0491 - IBRUTINIB [420 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 99% |
| 2026-09-22 | 2023/0491 - IBRUTINIB [560 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 99% |
| 2026-10-13 | 2023/0491 - PONATINIB [15 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-10-13 | 2023/0491 - BARICITINIB [4 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-10-13 | 2023/0491 - RUXOLITINIB [15 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |